Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

Clinical trial NCT07460765 · RECRUITING

Trial details

NCT number: NCT07460765
Sponsor: Vanderbilt-Ingram Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hnscc Head and Neck Squamous Cell Cancer Squamous Carcinoma Squamous Cell Cancer of Head and Neck (SCCHN)Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)Squamous Cell Carcinoma Mouth Squamous Carcinoma Poorly Differentiated Squamous Cell Cancer of the Head and Neck Squamous Cell Carcinoma (SCC) of the Oral Cavity Squamous Cell Carcinoma (SCC)

Start date: 2026-07-01
Primary completion: 2030-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.